 by BLOOMBERG Johnson Johnson halted clinical trials of its Covid-19 vaccine after a participant fell ill, the second time that a front-runner developer has paused testing in the race to create a viable immunisation against the virus. The participants illness is being evaluated, the New Brunswick, New Jersey-based company said late Monday, adding that it ... 